Skip to main content
. 2024 Oct 1;14:22777. doi: 10.1038/s41598-024-73418-4

Table 1.

Baseline characteristics.

All patients (n = 65)
Female 27 (41.5)
Age in years, mean ± standard deviation 46.8 ± 10.1
Hypertension 28 (43.1)
Diabetes 2 (3.1)
Hyperlipidemia 12 (18.5)
Smoking 21 (32.3)
Old cerebrovascular accident 3 (4.6)
Family history of stroke 13 (20)
Initial symptoms
 Ischemic symptom 45 (69.2)
 Headache 20 (30.8)
Treatments
 Aspirin 52 (80)
 Clopidogrel 36 (55.4)
 Statin 47 (72.3)
Location of dissection (n = 73)
 ACA 5 (6.8)
 MCA 4 (5.5)
 PCA 6 (8.2)
 BA 2 (2.7)
 VA 38 (52.1)
 PICA 18 (24.7)
Clinical outcomes (n = 65)
 Recurred or newly developed symptom 13 (20)
  Headache 8 (12.3)
  Dizziness 3 (4.6)
  Ataxic gait 2 (3.1)
 Asymptomatic 52 (80)
Final morphology (n = 73)
 Aneurysmal dilatation 16 (21.9)
  Progressive enlargement 7 (9.6)
  Non-progressive enlargement 9 (12.3)
 Occlusion 5 (6.8)
 Incomplete normalization with residual stenosis 24 (32.9)
 Complete normalization 28 (38.4)

Data are expressed as the number of cases with percentages in parentheses unless otherwise indicated. ACA anterior cerebral artery; MCA middle cerebral artery; PCA posterior cerebral artery; BA basilar artery; VA vertebral artery; PICA posterior inferior cerebellar artery.